Acquisition by William Duke of 150000 shares of Apexigen subject to Rule 16b-3
APGNDelisted Stock | USD 0.43 0.01 2.27% |
About 62% of Apexigen's investor base is looking to short. The analysis of current outlook of investing in Apexigen suggests that many traders are alarmed regarding Apexigen's prospects. Apexigen's investing sentiment overview a quick insight into current market opportunities from investing in Apexigen. Many technical investors use Apexigen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Apexigen |
Filed transaction by Apexigen Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at zacks.com
Apexigen Fundamental Analysis
We analyze Apexigen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apexigen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apexigen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Apexigen is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Apexigen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Apexigen stock to make a market-neutral strategy. Peer analysis of Apexigen could also be used in its relative valuation, which is a method of valuing Apexigen by comparing valuation metrics with similar companies.
Peers
Apexigen Related Equities
XFOR | X4 Pharmaceuticals | 11.43 | ||||
IMMX | Immix Biopharma | 7.11 | ||||
ENVB | Enveric Biosciences | 3.13 | ||||
PHIO | Phio Pharmaceuticals | 3.03 | ||||
LPTX | Leap Therapeutics | 2.05 | ||||
ZURA | Zura Bio | 1.67 | ||||
OCEA | Ocean Biomedical | 1.41 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |